Evidence map

ArticleKidney international2020

More reasons to use SGLT2 inhibitors: EMPEROR-reduced and DAPA-CKD.

Masaomi NangakuPubMed ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33068607